Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Lean Rx vs OnlyRx

Lean Rx
Graded #318

Lower grade

vs+0.29999999999999716
OnlyRx
Graded #309

Higher grade

The verdict

OnlyRx takes it — 60.9/100 to 60.6/100, but only just.

OnlyRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. OnlyRx is a cash-pay GLP-1 telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral disintegrating tablet (ODT) forms — an uncommon needle-free option. Lean Rx is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOnlyRx +2
40
42
Dose & formulationOnlyRx +13
75
88
Clinical oversightLean Rx +9
81
72
Labs & monitoringEven
52
52
FulfillmentLean Rx +8
60
52
Contract termsEven
55
55
Lean Rx · left barOnlyRx · right bar

The numbers

MetricLean RxOnlyRx
WeighScore60.6/10060.9/100
GradeCC
Scorecard rank#318#309
Semaglutide$266/mo (starting dose, compounded)$179/mo (starting dose, promotional rate, compounded)
Tirzepatide$399/mo (starting dose, compounded)$249/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesYes
Lean Rx

Graded #318 · C

Strengths

  • Both semaglutide and tirzepatide offered
  • Three formulations: injectable, sublingual, and tablet
  • Upfront pricing with no hidden fees advertised
  • Semaglutide starts at a low $266/month
  • Telehealth call with a licensed provider before prescribing

Where it loses points

  • Compounded-only; no FDA-approved branded options
  • No published state availability list
  • Platform is technology only, not a healthcare provider itself
  • Provider credentials not detailed on site
OnlyRx

Graded #309 · C

Strengths

  • Four-pharmacy network: Belmar, Strive, Epiq Scripts, and Casa Pharma RX
  • Named prescribers on the public site: Dr. Carr (MD), Dr. Tenbrink (MD), Dr. Italia (MD), Dr. Mansour (DO)
  • Oral disintegrating tablet (ODT) form for both semaglutide and tirzepatide — good for needle-averse patients
  • Pricing, drug list, pharmacy partners, and physician roster all visible on the public site
  • LegitScript Certified

Where it loses points

  • Promo pricing ($179 semaglutide injection) is prominent, but post-promo maintenance pricing isn't shown
  • No titration-ladder pricing — you can't see costs at 1.0 mg or 2.4 mg maintenance
  • Refund / cancellation policy not stated on the homepage
  • Lab-work requirement not stated
  • Operating corporate entity not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard